Question 1

What is Insomnia?

Accepted Answer

Insomnia is a common sleep-wake disorder characterized by both nocturnal and diurnal symptoms. It involves a predominant complaint of dissatisfaction with sleep quality or duration. It is accompanied by difficulties initiating sleep at bedtime, frequent or prolonged awakenings, or early-morning awakening with an inability to return to sleep. According to the American Academy of Sleep Medicine, Insomnia is defined as difficulty falling or staying asleep accompanied by daytime impairments related to those sleep troubles.

Question 2

Which country is expected to account for the highest prevalent cases of Insomnia among the 7MM?

Accepted Answer

Among the 7MM, the United States accounted for nearly 67% of the total diagnosed prevalent cases of insomnia in the year 2021. These cases are expected to increase further during the study period (2019–2032).

Question 3

How is Insomnia epidemiology segmented?

Accepted Answer

Insomnia epidemiology is segmented as Total Diagnosed Prevalent Cases of Insomnia, Type-specific Cases of Insomnia, Gender-specific Cases of Insomnia, and Age-specific Cases of Insomnia scenario of Insomnia in the 7MM covering the United States, EU4 (Germany, France, Italy, Spain), and the UK, and Japan from 2019 to 2032.

Question 4

What are the emerging Insomnia drugs?

Accepted Answer

The emerging drugs in the Insomnia therapeutics market include HETLIOZ (tasimelteon), Vornorexant (TS-142), Seltorexant (JNJ-42847922), and many more.

Question 5

Which companies are working in the Insomnia therapeutics market?

Accepted Answer

The leading companies working in the Insomnia market include Vanda Pharmaceuticals, Janssen Pharmaceutical, Taisho Pharmaceutical, Neurim Pharmaceuticals, Imbrium Therapeutics, Defined Research, and many others.

Question 6

What are the Key strengths of the Insomnia Market Report?

Accepted Answer

The report covers an in-depth assessment of the market, and the key strengths of the Insomnia Market Report are as follows: 11 Years Forecast, 7MM Coverage, Epidemiology Segmentation, Market Size and Trends Analysis, Drug Uptake, Pipeline Therapies, Market Drivers and Barriers, along with the key companies working in the market.